140 related articles for article (PubMed ID: 876500)
1. [Sympathetic nervous activity and ischemic cardiopathy].
Muiesan G; Valori C
Minerva Med; 1977 Jun; 68(31):2183-92. PubMed ID: 876500
[No Abstract] [Full Text] [Related]
2. [The sympathetic nervous system and coronary heart disease].
Richardt G; Grimm M; Haass M
Dtsch Med Wochenschr; 2000 Feb; 125(6):159-64. PubMed ID: 10700880
[No Abstract] [Full Text] [Related]
3. [Effect of electrosleep on the sympathetic-adrenal system of patients with ischemic heart disease associated with angina pectoris].
Efendieva AT
Vopr Kurortol Fizioter Lech Fiz Kult; 1976; (1):26-32. PubMed ID: 1014413
[No Abstract] [Full Text] [Related]
4. [Use of the beta adrenergic blockader test for evaluation of extracardiac regulation of heart function in patients with coronary pathology of various degrees of severity].
Duman VL; Rozhdestvenskaia ED; Oranskiĭ IE
Ter Arkh; 1984; 56(12):22-5. PubMed ID: 6151751
[TBL] [Abstract][Full Text] [Related]
5. [The effect of contrasting baths on the autonomic regulation of cardiac activity in patients with ischemic heart disease (stable stenocardia and postinfarct cardiosclerosis)].
Sorokina EI; Olefirenko VT; Sandakhmedova IV
Vopr Kurortol Fizioter Lech Fiz Kult; 1990; (2):32-6. PubMed ID: 2385939
[No Abstract] [Full Text] [Related]
6. Sympathetic nervous system activity and the heart.
Cohn JN
Am J Hypertens; 1989 Dec; 2(12 Pt 2):353S-356S. PubMed ID: 2532019
[TBL] [Abstract][Full Text] [Related]
7. [Effect of obzidan on the indices of gas exchange and the sympathetic-adrenal system in ischemic heart disease patients with different types of circulation].
Katsenovich RA; Kostko SZ; Kozhinskiĭ VM; Kuchenkova MA
Ter Arkh; 1984; 56(9):51-3. PubMed ID: 6515548
[TBL] [Abstract][Full Text] [Related]
8. [Combined use of orthostatic and hyperventilation tests with beta-adrenergic blockage in the interpretation of primary electrocardiographic changes in the ventricular repolarization phase].
Lukasik S; Wrabec K; Nowosad H; Chwistecki K
Pol Tyg Lek; 1974 Jun; 29(25):1067-71. PubMed ID: 4152269
[No Abstract] [Full Text] [Related]
9. Role of catecholamines and sympathetic activation as a risk factor for coronary artery disease.
Amadi A; Ponikowski P; Coats AJ
J Cardiovasc Risk; 1995 Jun; 2(3):222-8. PubMed ID: 7584797
[TBL] [Abstract][Full Text] [Related]
10. [The role of contraction asynchronism of the heart ventricles in the pathogenesis of pulmonary hypertension in ischemic heart disease].
Denisiuk VI
Vrach Delo; 1988 Jul; (7):31-3. PubMed ID: 3188459
[No Abstract] [Full Text] [Related]
11. Catecholamines in normal and abnormal cardiac function.
Manger WM
Adv Cardiol; 1982; 30():1-145. PubMed ID: 6758499
[No Abstract] [Full Text] [Related]
12. [Relationship between the activity of sympathico-adrenal system and clinico-physiological parameters in patients with ischemic heart disease during inderal therapy].
Orlov VN; Chigrinova LS
Ter Arkh; 1982; 54(5):53-7. PubMed ID: 7115506
[No Abstract] [Full Text] [Related]
13. [Dual nature of pain in angina pectoris and myocardial infarct].
Gaevskiĭ IuG
Ter Arkh; 1973; 45(6):93-5. PubMed ID: 4755058
[No Abstract] [Full Text] [Related]
14. ["Silent" myocardial ischemia and the activity of the sympathetic-adrenal system in hypertension patients].
Iurenev AP; De Quattro V; Titov VN; Guliaev VP; Kuz'min AI; Koniaeva EB
Ter Arkh; 1991; 63(9):83-7. PubMed ID: 1836901
[TBL] [Abstract][Full Text] [Related]
15. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
Schömig A; Richardt G; Kurz T
Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients].
Zaslavskaia RM; Zolotaia RD; Olevskiĭ IKh; Duda SG; Vilkovyskiĭ FA
Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152
[TBL] [Abstract][Full Text] [Related]
17. [Unusual electrocardiographic patterns during coronary cardiopathy].
Perna N; Chieffo C
Rass Int Clin Ter; 1967 Nov; 47(22):1254-68. PubMed ID: 5617803
[No Abstract] [Full Text] [Related]
18. [Activity of the sympathetic-adrenal system in ischemic heart disease during treatment with obsidan].
Orlov VN; Chigrinova LS
Sov Med; 1981; (1):21-6. PubMed ID: 7244775
[No Abstract] [Full Text] [Related]
19. Role of the sympathetic nervous system in the pathogenesis of chronic stable angina. Implications for the mechanism of action of beta-blockers.
Chierchia S; Muiesan L; Davies A; Balasubramian V; Gerosa S; Raftery EB
Circulation; 1990 Sep; 82(3 Suppl):II71-81. PubMed ID: 1975525
[TBL] [Abstract][Full Text] [Related]
20. Myocardial energetics: basic principles and clinical implications.
Sonnenblick EH; Skelton CL
N Engl J Med; 1971 Sep; 285(12):668-75. PubMed ID: 4935226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
